Pharmaceuticals
-
{
- All
- News
- Videos
-
Government Proposes Pharma Distribution Norms, Eases Revised Schedule M Rules For Select Drug Categories
- Thursday November 19, 2026
- Health | Indo Asian News Service
The Union Ministry of Health and Family Welfare proposed amendments to the Drugs Rules, 1945, aimed at strengthening pharmaceutical quality management and distribution systems, while providing regulatory flexibility for certain categories of drug products under the revised Schedule M framework.
-
www.ndtv.com/health
-
Indians Spend Rs 4.06 Lakh Crore On Healthcare: Key Findings From India's Health Report
- Sunday November 15, 2026
- Health | Reported by Tanushka Dutta, Edited by Sambhav Kumar
India's healthcare expenditure figures for 2023-24 point towards two contrasting developments. On one hand, government health spending has increased more than threefold over a decade.
-
www.ndtv.com/health
-
Centre Directs Strict Vigil To Enforce Lower Prices For 137 Anti-Cancer Drugs
- Friday November 13, 2026
- Health | Indo Asian News Service
The National Pharmaceutical Pricing Authority (NPPA) has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.
-
www.ndtv.com/health
-
India Remains Critical Drug Supplier To US As It Seeks Pharma Self-Reliance: Report
- Tuesday November 10, 2026
- Health | Indo Asian News Service
India's vast pharmaceutical manufacturing network has emerged as a critical pillar of the US healthcare system, highlighting the challenges facing American President Donald Trump's efforts to bring generic drug production back to the United States, according to a report.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed By Up To 96.45%; Annual Consumer Savings Pegged At Rs 3,540 Crore: Government
- Monday November 9, 2026
- Health | Indo Asian News Service
The government on Monday said revised prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.
-
www.ndtv.com/health
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Government Proposes Immediate Suspension Of Licences For Substandard Drugs: What It Means For Patients
- Thursday November 5, 2026
- Health | Written by Sambhav Kumar
The Health Ministry proposes amending Drugs Rules to allow instant suspension of manufacturing licences for substandard medicines failing critical quality checks.
-
www.ndtv.com/health
-
Health Ministry Aims To Align Grade A Microbial Monitoring Requirements With WHO Norms
- Wednesday November 4, 2026
- Health | Indo Asian News Service
The government on Wednesday said it has proposed amendments to Schedule M' of the Drugs Rules 1945, to revise the prescribed limits for microbial contamination in Grade A clean areas in accordance with the World Health Organisation (WHO) guidelines.
-
www.ndtv.com/health
-
Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates
- Wednesday November 4, 2026
- Author: Maumita Mitra
Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
-
www.ndtvprofit.com
-
India's Affordable Medicines, Digital Health Model Emulatable: Report
- Tuesday November 3, 2026
- Health | Indo Asian News Service
India is emerging as a global healthcare partner through affordable medicines, large-scale public health programmes, digital innovation and traditional medicine research, offering a model that developing economies can emulate to improve healthcare access and resilience, a new report has said.
-
www.ndtv.com/health
-
Emcure Pharmaceuticals Q2 Results: Profit Jumps 34%, Revenue Up 24%
- Tuesday November 3, 2026
- Author: Maumita Mitra, Edited by: Hemarghya Bal
Emcure Pharmaceuticals' international business grew 34.5% year-on-year in the September quarter, led by strong performances across Europe, Canada, and rest of the world markets.
-
www.ndtvprofit.com
-
Will Weight-Loss Drugs Hurt Fast Food And Alcohol Companies? Harsh Goenka Flags Industry Shift
- Tuesday November 3, 2026
- Offbeat | Edited by Nikhil Pandey
Industrialist Harsh Goenka has highlighted the potential winners and losers, pointing to a major shift in consumer behaviour that businesses may need to prepare for.
-
www.ndtv.com
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
- Friday October 30, 2026
- Health | Written by Debosmita Ghosh
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Centre Expects Anti-Cancer Drug Prices To Fall 20-70 Per Cent Under Proposed Trade Margin Cap
- Friday October 23, 2026
- Health | Indo Asian News Service
The Centre has told the Supreme Court that capping trade margins on anti-cancer medicines at 30 per cent of their maximum retail price (MRP) is expected to save patients around Rs 2,500 crore annually, with the proposed measure likely to reduce the MRP of such drugs by 20 to 70 per cent.
-
www.ndtv.com/health
-
Government Proposes Pharma Distribution Norms, Eases Revised Schedule M Rules For Select Drug Categories
- Thursday November 19, 2026
- Health | Indo Asian News Service
The Union Ministry of Health and Family Welfare proposed amendments to the Drugs Rules, 1945, aimed at strengthening pharmaceutical quality management and distribution systems, while providing regulatory flexibility for certain categories of drug products under the revised Schedule M framework.
-
www.ndtv.com/health
-
Indians Spend Rs 4.06 Lakh Crore On Healthcare: Key Findings From India's Health Report
- Sunday November 15, 2026
- Health | Reported by Tanushka Dutta, Edited by Sambhav Kumar
India's healthcare expenditure figures for 2023-24 point towards two contrasting developments. On one hand, government health spending has increased more than threefold over a decade.
-
www.ndtv.com/health
-
Centre Directs Strict Vigil To Enforce Lower Prices For 137 Anti-Cancer Drugs
- Friday November 13, 2026
- Health | Indo Asian News Service
The National Pharmaceutical Pricing Authority (NPPA) has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.
-
www.ndtv.com/health
-
India Remains Critical Drug Supplier To US As It Seeks Pharma Self-Reliance: Report
- Tuesday November 10, 2026
- Health | Indo Asian News Service
India's vast pharmaceutical manufacturing network has emerged as a critical pillar of the US healthcare system, highlighting the challenges facing American President Donald Trump's efforts to bring generic drug production back to the United States, according to a report.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed By Up To 96.45%; Annual Consumer Savings Pegged At Rs 3,540 Crore: Government
- Monday November 9, 2026
- Health | Indo Asian News Service
The government on Monday said revised prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.
-
www.ndtv.com/health
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Government Proposes Immediate Suspension Of Licences For Substandard Drugs: What It Means For Patients
- Thursday November 5, 2026
- Health | Written by Sambhav Kumar
The Health Ministry proposes amending Drugs Rules to allow instant suspension of manufacturing licences for substandard medicines failing critical quality checks.
-
www.ndtv.com/health
-
Health Ministry Aims To Align Grade A Microbial Monitoring Requirements With WHO Norms
- Wednesday November 4, 2026
- Health | Indo Asian News Service
The government on Wednesday said it has proposed amendments to Schedule M' of the Drugs Rules 1945, to revise the prescribed limits for microbial contamination in Grade A clean areas in accordance with the World Health Organisation (WHO) guidelines.
-
www.ndtv.com/health
-
Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates
- Wednesday November 4, 2026
- Author: Maumita Mitra
Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.
-
www.ndtvprofit.com
-
India's Affordable Medicines, Digital Health Model Emulatable: Report
- Tuesday November 3, 2026
- Health | Indo Asian News Service
India is emerging as a global healthcare partner through affordable medicines, large-scale public health programmes, digital innovation and traditional medicine research, offering a model that developing economies can emulate to improve healthcare access and resilience, a new report has said.
-
www.ndtv.com/health
-
Emcure Pharmaceuticals Q2 Results: Profit Jumps 34%, Revenue Up 24%
- Tuesday November 3, 2026
- Author: Maumita Mitra, Edited by: Hemarghya Bal
Emcure Pharmaceuticals' international business grew 34.5% year-on-year in the September quarter, led by strong performances across Europe, Canada, and rest of the world markets.
-
www.ndtvprofit.com
-
Will Weight-Loss Drugs Hurt Fast Food And Alcohol Companies? Harsh Goenka Flags Industry Shift
- Tuesday November 3, 2026
- Offbeat | Edited by Nikhil Pandey
Industrialist Harsh Goenka has highlighted the potential winners and losers, pointing to a major shift in consumer behaviour that businesses may need to prepare for.
-
www.ndtv.com
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
- Friday October 30, 2026
- Health | Written by Debosmita Ghosh
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Centre Expects Anti-Cancer Drug Prices To Fall 20-70 Per Cent Under Proposed Trade Margin Cap
- Friday October 23, 2026
- Health | Indo Asian News Service
The Centre has told the Supreme Court that capping trade margins on anti-cancer medicines at 30 per cent of their maximum retail price (MRP) is expected to save patients around Rs 2,500 crore annually, with the proposed measure likely to reduce the MRP of such drugs by 20 to 70 per cent.
-
www.ndtv.com/health